← Back to Search

Virtually Administered Cardiac Rehab Program for Heart Failure (VIRT-CR Trial)

N/A
Waitlist Available
Led By Neel Chokshi, MD
Research Sponsored by University of Pennsylvania
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patients who have been prescribed cardiac rehabilitation as part of their standard of care
Be older than 18 years old
Must not have
Patients who are unable to exercise in home
Patients with active cancer treatment
Timeline
Screening 3 weeks
Treatment Varies
Follow Up labs will be collected up to 27 months post study enrollment
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing whether a home-based cardiac rehab program with real-time, video-based exercise supervision and vitals monitoring is effective.

Who is the study for?
This trial is for heart failure patients who've been prescribed cardiac rehab. Participants need to have an email and cell phone, be able to exercise at home, and not have severe exercise limitations or active cancer treatment.
What is being tested?
The study compares a virtual cardiac rehab program with real-time video supervision against the standard in-person approach. It aims to see if patients can effectively perform rehab at home with remote guidance.
What are the potential side effects?
Since this trial involves exercise as part of cardiac rehabilitation, potential side effects may include muscle soreness, fatigue, and in rare cases, cardiovascular events due to exertion.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been prescribed cardiac rehabilitation.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I cannot exercise at home.
Select...
I am currently receiving treatment for cancer.
Select...
I do not have an email address or a cell phone.
Select...
I have exercise limitations not caused by heart problems.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~labs will be collected up to 27 months post study enrollment
This trial's timeline: 3 weeks for screening, Varies for treatment, and labs will be collected up to 27 months post study enrollment for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in VO2 max (ml/kg/min)
Secondary study objectives
Attendance
Blood Pressure
Change in HDL
+5 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Active Control
Group I: InterventionActive Control1 Intervention
Virtual cardiac rehab program delivered through the CardaHealth platform.
Group II: ControlActive Control1 Intervention
Clinically ordered standard of care cardiac rehab program (in-person).

Find a Location

Who is running the clinical trial?

Independence Blue CrossUNKNOWN
6 Previous Clinical Trials
126,312 Total Patients Enrolled
1 Trials studying Heart Failure
700 Patients Enrolled for Heart Failure
University of PennsylvaniaLead Sponsor
2,084 Previous Clinical Trials
42,726,481 Total Patients Enrolled
47 Trials studying Heart Failure
10,970 Patients Enrolled for Heart Failure
CardaHealthUNKNOWN
Neel Chokshi, MDPrincipal InvestigatorUniversity of Pennsylvania
Srinath Adusumalli, MDPrincipal InvestigatorUniversity of Pennsylvania
~13 spots leftby Dec 2025